GSK (GSK) News Today $38.02 -0.26 (-0.68%) As of 12:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GSK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period US FDA approves pre-filled version of GSK's shingles vaccine5 hours ago | reuters.comCable Hill Partners LLC Acquires Shares of 6,993 GSK PLC Sponsored ADR (NYSE:GSK)July 17 at 7:13 AM | marketbeat.comUS FDA Approves GSK's SHINGRIX in a Prefilled Syringe PresentationJuly 17 at 7:00 AM | businesswire.comGSK PLC Sponsored ADR (NYSE:GSK) Stake Cut by Whittier Trust Co.July 17 at 5:48 AM | marketbeat.comGSK’s Blenrep US comeback hindered by eye safety concernsJuly 16 at 5:54 PM | finance.yahoo.comGSK PLC Sponsored ADR (NYSE:GSK) is Equity Investment Corp's 4th Largest PositionJuly 16 at 8:44 AM | marketbeat.comCullen Frost Bankers Inc. Boosts Stake in GSK PLC Sponsored ADR (NYSE:GSK)July 16 at 8:15 AM | marketbeat.comFDA staff flags eye safety risks for GSK's blood cancer drugJuly 15 at 7:38 PM | msn.comGSK slides Tuesday, underperforms marketJuly 15 at 2:38 PM | marketwatch.comFDA staff raises eye damage concerns for GSK's blood cancer drugJuly 15 at 9:36 AM | msn.comFDA staff raises eye damage concerns for GSK's blood cancer drugJuly 15 at 8:51 AM | reuters.comGSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish StanceJuly 15 at 4:32 AM | msn.comSee what £10k invested in ailing GSK shares is worth today…July 15 at 4:32 AM | msn.comViiV expands licence to allow generic HIV treatment production for low-income countriesJuly 15 at 4:32 AM | msn.comBank of New York Mellon Corp Raises Stake in GSK PLC Sponsored ADR (NYSE:GSK)July 15 at 3:30 AM | marketbeat.comGSK seeks FDA green light for expanded use of RSV vaccine ArexvyJuly 14 at 6:35 AM | lse.co.ukKathmere Capital Management LLC Acquires Shares of 7,463 GSK PLC Sponsored ADR (NYSE:GSK)July 14 at 5:06 AM | marketbeat.comGSK PLC Sponsored ADR (NYSE:GSK) Shares Acquired by Cerity Partners LLCJuly 14 at 4:52 AM | marketbeat.comBrown Advisory Inc. Trims Holdings in GSK PLC Sponsored ADR (NYSE:GSK)July 14 at 4:16 AM | marketbeat.comGSK seeks FDA nod for expanded use of RSV vaccine in adultsJuly 14 at 2:42 AM | reuters.comGSK PLC Sponsored ADR (NYSE:GSK) Shares Acquired by Envestnet Asset Management Inc.July 11, 2025 | marketbeat.comGSK’s Promising Phase 2b Study on Atopic Dermatitis TreatmentJuly 10, 2025 | tipranks.comGSK’s Belimumab Study: A Potential Game-Changer for SSc-ILD TreatmentJuly 10, 2025 | tipranks.comGSK advances Thursday, outperforms marketJuly 10, 2025 | marketwatch.comGSK begins shipping influenza vaccine doses for the 2025-26 flu seasonJuly 10, 2025 | businesswire.comMoloney Securities Asset Management LLC Purchases Shares of 44,679 GSK PLC Sponsored ADR (NYSE:GSK)July 9, 2025 | marketbeat.comGSK’s Promising Phase 2b Study on Atopic Dermatitis TreatmentJuly 8, 2025 | tipranks.comGSK acquires efimosfermin alfa from Boston Pharma for $2bnJuly 8, 2025 | finance.yahoo.comMay Hill Capital LLC Buys New Holdings in GSK PLC Sponsored ADR (NYSE:GSK)July 8, 2025 | marketbeat.comHourglass Capital LLC Makes New Investment in GSK PLC Sponsored ADR (NYSE:GSK)July 8, 2025 | marketbeat.comFinancial Counselors Inc. Reduces Position in GSK PLC Sponsored ADR (NYSE:GSK)July 8, 2025 | marketbeat.comGSK PLC Sponsored ADR (NYSE:GSK) Shares Acquired by U.S. Capital Wealth Advisors LLCJuly 7, 2025 | marketbeat.comSimmons Bank Has $2.16 Million Stake in GSK PLC Sponsored ADR (NYSE:GSK)July 6, 2025 | marketbeat.comGSK’s Promising IPF Drug Study: A Potential Game Changer for InvestorsJuly 4, 2025 | tipranks.comAurora Private Wealth Inc. Makes New $692,000 Investment in GSK PLC Sponsored ADR (NYSE:GSK)July 4, 2025 | marketbeat.comGSK’s New COPD Study: A Potential Game-Changer for Respiratory TreatmentJuly 3, 2025 | tipranks.comAmeritas Advisory Services LLC Sells 17,908 Shares of GSK PLC Sponsored ADR (NYSE:GSK)July 3, 2025 | marketbeat.comGSK’s New IPF Drug Study: Potential Market ImpactJuly 2, 2025 | tipranks.comYelin Lapidot Holdings Management Ltd. Raises Holdings in GSK PLC Sponsored ADR (NYSE:GSK)July 2, 2025 | marketbeat.comMiller Howard Investments Inc. NY Acquires 955,891 Shares of GSK PLC Sponsored ADR (NYSE:GSK)July 2, 2025 | marketbeat.comInvestors Buy Large Volume of Put Options on GSK (NYSE:GSK)July 1, 2025 | marketbeat.com9,644 Shares in GSK PLC Sponsored ADR (NYSE:GSK) Acquired by Diversified Trust CoJuly 1, 2025 | marketbeat.comGSK PLC Sponsored ADR (NYSE:GSK) Given Consensus Recommendation of "Hold" by BrokeragesJuly 1, 2025 | marketbeat.comModerna says flu shot more effective than rival GSK in late-stage studyJune 30, 2025 | msn.comGSK’s Innovative Hepatitis B Treatment Study: Market Implications and ProgressJune 30, 2025 | tipranks.comGSK PLC Sponsored ADR (NYSE:GSK) Shares Acquired by Argent Advisors Inc.June 30, 2025 | marketbeat.comZollinger Ellison Syndrome Market Analysis Report 2025: Novartis, GSK, Bayer, Pfizer, and Bristol Myers Squibb DominateJune 28, 2025 | finance.yahoo.comGSK’s Momelotinib Study: A Potential Breakthrough for Low-risk Myelodysplastic SyndromeJune 27, 2025 | tipranks.comUS Senator investigates GSK for pulling children's asthma inhalerJune 27, 2025 | reuters.comEnvestnet Portfolio Solutions Inc. Sells 28,957 Shares of GSK PLC Sponsored ADR (NYSE:GSK)June 27, 2025 | marketbeat.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.600.96▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼2419▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Today Novartis News Today AstraZeneca News Today Sanofi News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today BioNTech News Today Insmed News Today Summit Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.